Identification of Rh alloantibody in Thalassaemia Patients

Authors

  • Nahid Sultana Medical Officer of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka
  • Atiar Rahman Assistant Professor of Transfusion Medicine, BSMMU, Dhaka
  • Fatema Easmin Medical Officer of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka
  • Md Mazharul Hoque Professor of Transfusion Medicine, Dhaka Medical College Hospital, Dhaka
  • Kashfia Islam Student of MD (Final part) Transfusion Medicine, BSMMU, Dhaka
  • Sonia Shormin Medical Officer of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka
  • Jolly Biswas Professor & Chairman of Transfusion Medicine, BSMMU, Dhaka

DOI:

https://doi.org/10.3329/jom.v17i2.30069

Keywords:

DCT (Direct Coomb’s Test), ICT (Indirect Coomb’s Test), Rh (Rhesus)

Abstract

Summary: Thalassaemiais a congenital hemolytic disorder caused by partial or complete deficiency of ? or ? globin chain synthesis. The disease is treated by lifelong red cell transfusion. So they are at high risk of developing allo-antibodies, resulting difficult to obtain compatible blood, results in, haemolysis & occasionally life threatening events.

Objectives: To find out the frequency of Rhesus alloantibodies among the thalassaemic patients.

Methods: This cross sectional study was done in the department of transfusion medicine in Bangabandhu Sheikh Mujib Medical University from 01-07-2010 to 03-07-2011. Sample size was 100 and the data was collected by face to face interview. Purposive sampling method was applied using inclusion & exclusion criteria. Statically analysis of the result was obtained by using window based computer software devised with Statistical Packages for Social Sciences (SPSS-15) (SPSS Inc, Chicago, IL, USA).

Result: In the present study all respondent were Rh D-positive. Out of 100 respondents 2 (2.0%) had positive direct Coombsand 6 (6.0%) had positive indirect Coomds test. Out of 6 respondent with Rhesus all-antibody, 4 (66.7%) had anti E antibody, 1(16.7%) had anti c antibody and 1 (16.7%) had non specific antibody.

Conclusion: In this study among the 100 respondents of thalassaemic patients who receive regular blood transfusion 6 (6.0%) had developed rhesus allo-antibody among with the most common was Anti E antibody 4 (66.7%). Such information may enable understanding and prevention of this serious and common complication.

J MEDICINE July 2016; 17 (2) : 79-83

Downloads

Download data is not yet available.
Abstract
44
PDF
48

Author Biography

Nahid Sultana, Medical Officer of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka



Downloads

Published

2016-10-23

How to Cite

Sultana, N., Rahman, A., Easmin, F., Hoque, M. M., Islam, K., Shormin, S., & Biswas, J. (2016). Identification of Rh alloantibody in Thalassaemia Patients. Journal of Medicine, 17(2), 79–83. https://doi.org/10.3329/jom.v17i2.30069

Issue

Vol. 17 No. 2 (2016)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).